1 year return (CAGR)
23.42%
Gain Therapeutics Inc Exchange (NASDAQ, USD)
GANX
1.95
+0.11 (+5.98%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-19.22%
5 year return (CAGR)
-23.86%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
85.11M
Price/Sales
-
Ent value
76.15M
Price/Book
7.54
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
0.03%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.85 |
| Daily high | 1.96 |
| Daily low | 1.82 |
| Daily Volume | 692K |
| All-time high | 15.80 |
| 1y analyst estimate | 7.20 |
| Beta | 0.20 |
| EPS (TTM) | -0.47 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Mar 2026 |
Downside potential
Loading...
Downside potential data
| GANX | S&P500 | |
| Current price drop from All-time high | -87.66% | -0.58% |
| Highest price drop | -94.08% | -56.47% |
| Date of highest drop | 13 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -76.11% | -10.68% |
| Avg time to new high | 154 days | 12 days |
| Max time to new high | 1374 days | 1805 days |
News
